China COVID-19 vaccine trials resume in Peru after 'adverse event'
Peru has resumed the clinical trials of China's Sinopharm COVID-19 vaccine after an "adverse event" in one of the volunteers was "clarified", Health Minister Pilar Mazzetti said. The clinical trials were suspended last week after neurological problems were detected in the volunteer. Sinopharm is conducting its trials in Peru with nearly 12,000 volunteers. 